241 related articles for article (PubMed ID: 12209010)
1. Position of aromatic residues in the S6 domain, not inactivation, dictates cisapride sensitivity of HERG and eag potassium channels.
Chen J; Seebohm G; Sanguinetti MC
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12461-6. PubMed ID: 12209010
[TBL] [Abstract][Full Text] [Related]
2. Transfer of rapid inactivation and sensitivity to the class III antiarrhythmic drug E-4031 from HERG to M-eag channels.
Herzberg IM; Trudeau MC; Robertson GA
J Physiol; 1998 Aug; 511 ( Pt 1)(Pt 1):3-14. PubMed ID: 9679158
[TBL] [Abstract][Full Text] [Related]
3. A structural basis for drug-induced long QT syndrome.
Mitcheson JS; Chen J; Lin M; Culberson C; Sanguinetti MC
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12329-33. PubMed ID: 11005845
[TBL] [Abstract][Full Text] [Related]
4. Molecular determinants of dofetilide block of HERG K+ channels.
Ficker E; Jarolimek W; Kiehn J; Baumann A; Brown AM
Circ Res; 1998 Feb; 82(3):386-95. PubMed ID: 9486667
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical features of the HERG channel drug binding site.
Fernandez D; Ghanta A; Kauffman GW; Sanguinetti MC
J Biol Chem; 2004 Mar; 279(11):10120-7. PubMed ID: 14699101
[TBL] [Abstract][Full Text] [Related]
6. Molecular determinants of voltage-dependent human ether-a-go-go related gene (HERG) K+ channel block.
Sánchez-Chapula JA; Navarro-Polanco RA; Culberson C; Chen J; Sanguinetti MC
J Biol Chem; 2002 Jun; 277(26):23587-95. PubMed ID: 11960982
[TBL] [Abstract][Full Text] [Related]
7. Effects of outer mouth mutations on hERG channel function: a comparison with similar mutations in the Shaker channel.
Fan JS; Jiang M; Dun W; McDonald TV; Tseng GN
Biophys J; 1999 Jun; 76(6):3128-40. PubMed ID: 10354437
[TBL] [Abstract][Full Text] [Related]
8. The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations.
Ficker E; Obejero-Paz CA; Zhao S; Brown AM
J Biol Chem; 2002 Feb; 277(7):4989-98. PubMed ID: 11741928
[TBL] [Abstract][Full Text] [Related]
9. Open channel block of HERG K(+) channels by vesnarinone.
Kamiya K; Mitcheson JS; Yasui K; Kodama I; Sanguinetti MC
Mol Pharmacol; 2001 Aug; 60(2):244-53. PubMed ID: 11455010
[TBL] [Abstract][Full Text] [Related]
10. Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain.
Sănchez-Chapula JA; Ferrer T; Navarro-Polanco RA; Sanguinetti MC
Mol Pharmacol; 2003 May; 63(5):1051-8. PubMed ID: 12695533
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of amino-terminal distal and proximal domains in the regulation of human erg K(+) channel gating.
Viloria CG; Barros F; Giráldez T; Gómez-Varela D; de la Peña P
Biophys J; 2000 Jul; 79(1):231-46. PubMed ID: 10866950
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes.
Suessbrich H; Schönherr R; Heinemann SH; Attali B; Lang F; Busch AE
Br J Pharmacol; 1997 Mar; 120(5):968-74. PubMed ID: 9138706
[TBL] [Abstract][Full Text] [Related]
13. Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride.
Mohammad S; Zhou Z; Gong Q; January CT
Am J Physiol; 1997 Nov; 273(5):H2534-8. PubMed ID: 9374794
[TBL] [Abstract][Full Text] [Related]
14. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.
Rampe D; Roy ML; Dennis A; Brown AM
FEBS Lett; 1997 Nov; 417(1):28-32. PubMed ID: 9395068
[TBL] [Abstract][Full Text] [Related]
15. Intracellular K+ is required for the inactivation-induced high-affinity binding of cisapride to HERG channels.
Lin J; Guo J; Gang H; Wojciechowski P; Wigle JT; Zhang S
Mol Pharmacol; 2005 Sep; 68(3):855-65. PubMed ID: 15967876
[TBL] [Abstract][Full Text] [Related]
16. Molecular determinants of hERG channel block by terfenadine and cisapride.
Kamiya K; Niwa R; Morishima M; Honjo H; Sanguinetti MC
J Pharmacol Sci; 2008 Nov; 108(3):301-7. PubMed ID: 18987434
[TBL] [Abstract][Full Text] [Related]
17. Mapping the binding site of a human ether-a-go-go-related gene-specific peptide toxin (ErgTx) to the channel's outer vestibule.
Pardo-Lopez L; Zhang M; Liu J; Jiang M; Possani LD; Tseng GN
J Biol Chem; 2002 May; 277(19):16403-11. PubMed ID: 11864985
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the human ether-a-go-go-related gene (HERG) potassium channel by cisapride: affinity for open and inactivated states.
Walker BD; Singleton CB; Bursill JA; Wyse KR; Valenzuela SM; Qiu MR; Breit SN; Campbell TJ
Br J Pharmacol; 1999 Sep; 128(2):444-50. PubMed ID: 10510456
[TBL] [Abstract][Full Text] [Related]
19. Long QT syndrome-associated mutations in the Per-Arnt-Sim (PAS) domain of HERG potassium channels accelerate channel deactivation.
Chen J; Zou A; Splawski I; Keating MT; Sanguinetti MC
J Biol Chem; 1999 Apr; 274(15):10113-8. PubMed ID: 10187793
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of inactivation and dofetilide block in ether a-go-go (EAG) channels and EAG-related K(+) channels.
Ficker E; Jarolimek W; Brown AM
Mol Pharmacol; 2001 Dec; 60(6):1343-8. PubMed ID: 11723241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
